Skip to main content

Retail Clinics

  • Health 2.0, Walgreens announce health guide challenge

    SAN FRANCISCO — Health 2.0 and Walgreens on Thursday announced the launch of the Walgreens 2011 Challenge: A New Approach to Patient Information Navigation, which invites teams of developers to create an application that presents aggregated U.S. Department of Health and Human Services data on specific health topics.

    The challenge is being sponsored by Walgreens, as part of the Health 2.0 Developer Challenge, as a way to supply both Walgreens healthcare staff and patients with a tool for searching and learning about health-related topics, the companies stated.

  • H1N1 flu variant may be resistant to certain treatments

    NEW YORK — A new strain of swine flu has emerged that appears somewhat resistant to flu drugs, according to published reports.

    Reuters reported that scientists in Australia and Singapore had found a variant of the H1N1 flu that showed some resistance to Roche’s Tamiflu (oseltamivir phosphate) and GlaxoSmithKline’s Relenza (zanamivir), though drug maker BioCryst currently is developing a drug called peramivir, to which the strain was not resistant.

  • MinuteClinic to collaborate with Cleveland Clinic Florida

    WOONSOCKET, R.I. — MinuteClinic and Cleveland Clinic Florida, a multispecialty academic medical center that is part of the Cleveland Clinic health system, have entered into a clinical affiliation to enhance the healthcare services they provide and offer patients greater access to care.

  • FDA recommends limiting use of simvastatin in 80-mg strength

    SILVER SPRING, Md. — The Food and Drug Administration is seeking to limit the use of high doses of a drug for high cholesterol due to the risk of a muscle injury known as myopathy.

  • FDA approves labeling change for Eli Lilly insulin product

    INDIANAPOLIS — Patients with Type 1 diabetes using an insulin product made by Eli Lilly can store it in their pumps for longer periods of time, while children using it have additional options, thanks to a labeling change approved Wednesday by the Food and Drug Administration.

  • Statin users can save money if they adhere to therapies, Medco finds

    FRANKLIN LAKES, N.J. — In a year and a half, patients taking statins to lower their cholesterol can save more than $900 when they take their medications as prescribed, according to a new study in the June 1 issue of the American Journal of Cardiology.

    The study, conducted by pharmacy benefit manager Medco Health Solutions’ research subsidiary, the Medco Research Institute, found that patients who adhered to their therapies saved as much as $944 over 18 months because they experienced fewer cardiovascular problems leading to hospitalization.

  • Walgreens, NMPG develop coordinated healthcare program

    DEERFIELD, Ill. — Walgreens and Northwestern Memorial Physicians Group of Chicago on Wednesday announced a new coordinated healthcare program in which Walgreens will share the results of appropriately timed pharmacist clinical interventions with primary care physicians of selected patients.

  • Actavis granted final approval for generic Ambien CR

    MORRISTOWN, N.J. — The Food and Drug Administration has given final approval to a generic drug for insomnia made by Actavis, the drug maker said Monday.

    The FDA approved the company’s zolpidem tartrate extended-release tablets in the 12.5-mg strength. The drug, which is a Schedule IV controlled substance, is a generic version of Sanofi’s Ambien CR. Actavis was the first company to launch a generic version of the drug in the 6.25-mg strength in October 2010.

X
This ad will auto-close in 10 seconds